Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

  • J. M. Connors
  • , W. Jurczak
  • , D. J. Straus
  • , S. M. Ansell
  • , W. S. Kim
  • , A. Gallamini
  • , A. Younes
  • , S. Alekseev
  • , A. Illés
  • , M. Picardi
  • , E. Lech-Maranda
  • , Y. Oki
  • , T. Feldman
  • , P. Smolewski
  • , K. J. Savage
  • , N. L. Bartlett
  • , J. Walewski
  • , R. Ramchandren
  • , P. L. Zinzani
  • , D. Cunningham
    • A. Rosta, N. C. Josephson, E. Song, J. Sachs, R. Liu, H. A. Jolin, D. Huebner, J. Radford, Rebort Chen, ECHELON-1 Study Group, Tzeon-Jye Chiou

Research output: Contribution to journal › Article › peer-review

666   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry